Subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist vs placebo/no treatment
Ongoing pregnancy · women trying to conceive by intrauterine insemination
It is very uncertain whether subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist changes ongoing pregnancy rate compared with placebo/no treatment (very low certainty).
1 finding from 1 review
- Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse 2022 · Cochrane Headline outcomes onlyRR 1.1 [0.7, 1.74]1 study · 291 participantsVery low